BioCentury
ARTICLE | Clinical News

Estradiol: Phase III data

October 3, 2005 7:00 AM UTC

In a 12-week, double-blind, placebo-controlled, U.S. and Canadian Phase III trial in 484 menopausal women, the most effective dose of Bio-E-Gel significantly decreased the number of hot flashes by 88%...